SCHEMBL20132775

SCHEMBL20132775

N[C@H](Cc1ccc(OC(F)(F)F)c(F)c1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRB2 P62993 1/20 0.54
PTPN1 P18031 3/20 0.53
SLC7A5 Q01650 7/20 0.50
PTGS1 P23219 2/20 0.50
EPHX2 P34913 1/20 0.50
KDM4E B2RXH2 1/20 0.50
USP2 O75604 1/20 0.50
EGFR P00533 1/20 0.50
LCK P06239 1/20 0.50
FYN P06241 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
ALOX15 P16050 1/20 0.50
HTR2A P28223 1/20 0.50
PTGS2 P35354 1/20 0.50
RECQL P46063 1/20 0.50
HIF1A Q16665 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
NR1I2 O75469 1/20 0.47
PPARG P37231 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30057038 0.88 SLC7A5 (0.51) GRB2PTPN1SLC7A5PTGS1KDM4E
SCHEMBL25186371 0.86 GRIK1 (0.47) GRB2PTPN1SLC7A5EPHX2PDE2A
SCHEMBL25186372 0.86 GRIK1 (0.47) GRB2PTPN1SLC7A5EPHX2PDE2A
SCHEMBL18893762 0.85 GRB2 (0.52) GRB2PTPN1SLC7A5PTGS1KDM4E
SCHEMBL16163306 0.85 GRB2 (0.52) GRB2PTPN1SLC7A5PTGS1KDM4E
SCHEMBL19929599 0.84 SLC7A5 (0.54) GRB2PTPN1SLC7A5PTGS1KDM4E
SCHEMBL31177566 0.84 EPHX2 (0.43) PTPN1SLC7A5PTGS1EPHX2PDE2A
Hydrochloric Acid SCHEMBL18893807 0.84 PTPN1 (0.51) GRB2PTPN1SLC7A5PTGS1KDM4E
Hydrochloric Acid SCHEMBL18893793 0.84 PTPN1 (0.51) GRB2PTPN1SLC7A5PTGS1KDM4E
SCHEMBL18174275 0.83 EPHX2 (0.50) EPHX2PPARGPDE2ALDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180127402-A1 ISOXAZOLYL SUBSTITUTED BENZIMIDAZOLES CELLCENTRIC LTD (GB) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127402-A1 ISOXAZOLYL SUBSTITUTED BENZIMIDAZOLES EP300, HDAC3, HDAC1 GRB2 421/4885PTPN1 2865/4885SLC7A5 4505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.